Cargando…
Old Problem in a New Guise: Retinal Pigment Epithelium Tear after Intravitreal Faricimab (Vabysmo(®)) Injection
This case report describes a 78-year-old patient who developed a tear of the retinal pigment epithelium (RPE) during faricimab (Vabysmo(®)) therapy. After three consecutive intravitreal aflibercept (Eylea(®)) injections with persistent disease activity, therapy was switched to faricimab. The patient...
Autores principales: | Clemens, Christoph R., Alten, Florian, Zimmermann, Julian A., Eter, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294021/ https://www.ncbi.nlm.nih.gov/pubmed/37383167 http://dx.doi.org/10.1159/000529930 |
Ejemplares similares
-
Retinal pigment epithelium tear after intravitreal aflibercept injection
por: Saito, Masaaki, et al.
Publicado: (2013) -
Retinal pigment epithelial tear following intravitreal injection of brolucizumab
por: Ashkenazy, Noy, et al.
Publicado: (2021) -
Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
por: Kusuhara, Sentaro, et al.
Publicado: (2023) -
Turnover of Microaneurysms After Intravitreal Injections of Faricimab for Diabetic Macular Edema
por: Takamura, Yoshihiro, et al.
Publicado: (2023) -
Intravitreal gas injection with prone positioning for giant retinal pigment epithelial tear
por: Singh, Deependra Vikram, et al.
Publicado: (2018)